21 C.F.R. § 350.1

Scope.

Last amended: 2016Year: 2026Length: 67 wordsSubsections: 2Official source

Cite as 21 C.F.R. § 350.1 (2026)

(a) An over-the-counter antiperspirant drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each condition in this part and each general condition established in § 330.1 of this chapter. (b) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.
Cross-references to the CFR
330.1
21 C.F.R. § 350.1: Scope. | Justis AI